Revenue cycle · Patient billing & payments
PatientPay
PatientPay is a digital patient billing and payments platform for medical groups and RCM partners, covering statements, online payment, and payment plans. It is not a claim-editing or autonomous coding engine.
Strong fit
- Medical groups and RCM partners that need digital patient billing, statements, and payment plans without a full enterprise patient-pay suite
- Teams that will measure patient-pay yield and statement cost after cutover
- Buyers comparing mid-market patient billing platforms rather than Cedar-scale engagement finance
Weak fit
- Health systems standardizing on an enterprise patient-estimate and CRM suite on day one
- Buyers who only need claim editing with no patient communications
- Organizations unwilling to change paper-statement habits
Bottom line
PatientPay earns a Recommend for mid-market groups whose patient-pay leak is statements, digital payments, and payment plans - not mid-cycle coding. Outcomes look strongest when paper volume drops and patient-pay cash improves after enrollment. Product depth sits with Collectly on patient billing automation, narrower than Phreesia when intake-plus-payments is the full job, and different from Aptarro on claim edits. Implementation is billing-ops and PM integration work. Pricing is custom; public list dollars are not posted. Third-party revenue estimates sit roughly $3-4M, at the low end of our prefer band. Score sits just under Collectly on our revenue-cycle patient-pay cluster.
Score breakdown
Weights: Outcomes 35% · Product 30% · Implementation 20% · Pricing clarity 15%.
PatientPay is a digital patient billing and payments platform for medical groups and RCM partners: statements, online pay, payment plans, and related patient-pay workflows.
Compare Collectly when you want broader patient billing automation, Phreesia when intake and payments ship together, and Aptarro when the leak is claim edits rather than patient collections.
Score reflects solid patient-pay marks with modest scale on our revenue-cycle board.
Competitor landscape
| Vendor | Overall | Ease of implementation |
|---|---|---|
| PatientPay | 7.0 | 7.0 |
| Collectly | 7.4 | 7.2 |
| Rivia Health | 6.5 | 6.4 |
| Aptarro | 7.0 | 6.8 |
| MDaudit | 7.4 | 7.1 |
| MD Clarity | 6.9 | 6.7 |
| Phreesia | 8.2 | 7.8 |
| Nym | 6.6 | 6.4 |
Pricing
| Item | Detail |
|---|---|
| Model | Custom SaaS for digital patient billing, statements, and payments; often sized to statement or payment volume. |
| What usually drives cost | Patient statement volume, payment volume, modules, and RCM-partner vs direct-provider packaging. |
| What to ask in diligence | Monthly cost at your statement volume, payment processing fees, and onboarding scope. |
| Published pricing | Public list price: not published. Expect a mid-market patient-pay quote. |
Prerequisites for purchase
| Need | Why it matters |
|---|---|
| What you need to get PatientPay to function | |
| RCM owner with authority to change edit and billing workflows | Software without owners becomes shelfware. |
| Baseline clean-claim, denial, or patient-pay metrics captured | You cannot prove value without a before number. |
| PM/EHR interface path and test claims ready | Orphan edits create more rework. |
| Staffing plan for work queues after go-live | Unowned queues age into write-offs. |
| Payer mix and top denial or statement reasons documented | Generic rules miss your real leaks. |
| What will maximize your value | |
| Track clean-claim rate or patient-pay yield weekly for 90 days | Feature tours are not outcomes. |
| Tune the top denial or statement reasons in month one | Boiling the ocean delays cash. |
| Turn off redundant manual workarounds after parallel week | Dual paths erase the gain. |
| Review aged work-queue items in a standing huddle | Silent aging hides failure. |
| Publish a monthly cash and denial digest to finance leaders | Hidden leakage surprises the CFO. |
| Deal-breakers | |
| Nobody will own edit or billing queues. | |
| You refuse PM/EHR interface work the product needs. | |
| You expect an EHR replacement from an RCM tool. | |
| Leadership will not measure cash or denial outcomes. | |
| Compliance blocks the patient-communication path you require. | |
Value creation time frame
| # | Stage | Typical range |
|---|---|---|
| 1 | Scope & baseline | 2–4 weeks — Metrics, interfaces, rule/statement scope. |
| 2 | Configure | 4–10 weeks — Rules, templates, PM hooks; test claims. |
| 3 | Pilot | 2–6 weeks — One entity or payer family. |
| 4 | Optimize | Ongoing — Rule tuning; queue burn-down. |
Methodology
| Weight | Factor | What it measures |
|---|---|---|
| 35% | Customer outcomes | Whether buyers get measurable operational or clinical-workflow results after go-live |
| 30% | Product | Capability depth, reliability, and fit for the job the category actually buys |
| 20% | Implementation | How hard it is to stand up, integrate, train, and stabilize |
| 15% | Pricing clarity | Whether a buyer can model total cost without a mystery quote |
| Label | Meaning |
|---|---|
| Highly recommend | Strong outcomes and product with manageable caveats |
| Recommend | Solid fit for the right buyer; know the tradeoffs |
| Conditional | Only with a specific use case or heavy caveats |
| Not recommended | Avoid for most buyers in this category |
Read our full methodology for how we weight scores and assign recommend labels.